Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fitzmaurice Hand Institute is a private U.S. specialty healthcare provider focused on hand, wrist, elbow, and upper-extremity conditions, with an emphasis on minimally invasive surgical and non-surgical treatment. The practice was founded by hand surgeon Dr. Michael Fitzmaurice and operates in the Phoenix/Scottsdale, Arizona area. It is best known for developing and offering the proprietary EndoTech minimally invasive hand surgery system and for operating the affiliated EndoTech Surgery Center. The organization markets treatment for common hand disorders such as carpal tunnel syndrome, trigger finger, tennis elbow, and De Quervain's disease rather than a drug-development pipeline. For a biotech analyst, this is best classified as a commercial healthcare services and medtech-enabled specialty practice, not a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fitzmaurice Hand Institute.